BoomerangFX Introduces LeadEngineAI™: The World’s First AI Platform Revolutionizing Lead Generation, Patient Conversion, and Retention for Private Healthcare
Unveils "AUVIA"™ — the AI-powered virtual assistant that generates leads, books consultations, and drives patient retention through intelligent automation. MIAMI, TORONTO, LONDON and SYDNEY, May 16, 2025 /PRNewswire/ -- BoomerangFX, the all-in-one artificial intelligence-powered platform for private-pay healthcare clinics, today announced the global launch of LeadEngineAI™—a breakthrough revenue-generation platform that combines AI, marketing automation, and...
NYSE Content Advisory: Pre-Market update + NYSE celebrates 233 years forward
NEW YORK, May 16, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Kristen Scholer delivers the pre-market update on May 16th U.S. equities trend higher,...
Gene Solutions and NEWCL Forge Strategic Partnership to Advance Genetic Testing in Taiwan
NEW TAIPEI CITY, May 16, 2025 /PRNewswire/ -- In a groundbreaking move, Gene Solutions, a leader in prenatal and oncology genetic testing, and NEWCL Biomedical Laboratory, Taiwan's pioneering clinical laboratory with LDTs certification, have joined forces to establish an advanced Next-Generation Sequencing (NGS) laboratory in Taiwan. This collaboration was sealed with the signing of a Memorandum of Understanding...
Blending Innovation with Tradition: Thailand Brings Holistic Wellness to Expo 2025
BANGKOK, May 16, 2025 /PRNewswire/ -- Within just the first month of Expo 2025 in Osaka, Japan, the Thai Pavilion has welcomed over 200,000 visitors charmed by Thailand's fusion of cutting-edge innovation and rich cultural heritage. Visitors come to explore the Thai Pavilion at Expo 2025 Osaka. Located in the Connecting Lives...
From Affordable Premiums to Holistic Care, Policybazaar Unveils Comprehensive Solutions for NRIs and Their Families in India
GURUGRAM, India, May 16, 2025 /PRNewswire/ -- Policybazaar, one of India's largest online insurance platforms, has launched, through its insurance partners, a comprehensive suite of initiatives tailored to the needs of Non-Resident Indians (NRIs) and their families residing in India. Why NRIs are Turning to Indian Health Insurance An increasing number of...
Genome & Company’s Skincare Brand UIQ Expands into North America with Official Amazon Brand Store Launch
Official debut signals full-scale entry into global markets Biome Barrier Cream Mist earns 'Amazon's Choice' designation SEOUL, South Korea, May 16, 2025 /PRNewswire/ -- Genome & Company, a global clinical-stage biotechnology firm, has officially launched its skincare brand UIQ (www.theuiq.com) on Amazon, the largest e-commerce platform in the United States. Genome &...
Nuance Pharma Announces Ensifentrine Meets Primary Endpoint in Phase 3 ENHANCE-CHINA Trial for COPD
Statistically significant improvements in lung function Consistent trends of quality of life and exacerbation rate reduction as ENHANCE-1/2 Well tolerated safety profile NDA submission planned for 2H 2025 SHANGHAI, May 16, 2025 /PRNewswire/ -- Nuance Pharma ("Nuance") today announces its top-line Phase 3 ENHANCE-CHINA (NCT05743075) trial results evaluating nebulized ensifentrine for the maintenance treatment of chronic...
MINISH Veneers Expands Global Footprint with Successful Dental Seminar in Los Angeles
SEOUL, South Korea, May 16, 2025 /PRNewswire/ -- Korean healthtech company MINISH Technology hosted a successful dental seminar and business briefing in Los Angeles on May 10th, marking its second international event and a key step in its North American expansion - following its successful launch in Tokyo. Following its inaugural overseas...
Nordic Bioscience launches novel Endotrophin assay
HERLEV, Denmark, May 16, 2025 /PRNewswire/ -- Nordic Bioscience introduces nordicEndotrophin™, a fully automated high-precision assay that selectively quantifies the intact 77-amino-acid Endotrophin signaling hormone—qualified in the CAP/CLIA certified Nordic Bioscience laboratory. When integrated with the company's existing product line, the biomarker assay demonstrated prognostic utility in fibrosis and cancer studies1. NordicEndotrophin™ joins...
Amorepacific and Johns Hopkins School of Medicine’s Joint Research Program ‘NBRI’ Participants Present Latest Findings
Skin anti-aging and immunity effects of Amorepacific's two proprietary ingredients, 'RE.D Flavonoid' and 'Senomune' revealed at the 2025 SID Annual Meeting SEOUL, South Korea, May 16, 2025 /PRNewswire/ -- Amorepacific has demonstrated the efficacy of its two proprietary ingredients in improving skin aging and immune response through the NBRI program, jointly operated with Johns Hopkins School of Medicine. The...
